Skip to Main Content

Improving diversity in Alzheimer's disease data

With guest Margaret Pericak-Vance, Ph.D.

November 10, 2022

GuestMargaret Pericak-Vance, Ph.D.
Listen Time: 28m 33s

Alzheimer’s research, from previous studies to ongoing clinical trials, is often not representative of the populations that are at the highest risk for this disease. Margaret Pericak-Vance, Ph.D., sits down with Dean Henri Ford to discuss a multi-center, multi-national clinical trial that will tackle this issue and expand diversity in Alzheimer’s data, eventually leading to the development of targeted drug therapies.

Listen on Apple Listen on iHeart Listen on Spotify


Margaret Pericak-Vance, Ph.D

Margaret Pericak-Vance, Ph.D

Director, John P. Hussman Institute for Human Genomics, Clinical and Translational Genetics

Biography: Dr. Pericak-Vance is Director of the John P. Hussman Institute for Human Genomics and Executive Vice Chair of the Dr. John T. Macdonald Foundation Department of Human Genetics at the University of Miami Miller School of Medicine. Board certified by the American Board of Medical Specialties in Medical Genetics, she is a founding fellow of the American College of Medical...
View Full Profile >